Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

SRIKANTH MALEMPATI

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1730284456
CMS profile
78966
Location
CLEARWATER, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$219.12

11 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $219.12 11

By paying entity

PY2024 · entire year · sorted by reported total

Paying entityAmountRecords
Bayer Healthcare Pharmaceuticals Inc. $55.19 2
GlaxoSmithKline, LLC. $37.77 2
AstraZeneca Pharmaceuticals LP $36.96 2
PFIZER INC. $30.63 2
Renalytix AI, Inc. $22.90 1
SI-BONE, INC. $21.25 1
Dexcom, Inc. $14.42 1

Page 1 of 1; records 1–11 of 11 matching records. This page contains 11 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

SRIKANTH MALEMPATI

NPI 1730284456 · CMS profile ID 78966

Allopathic & Osteopathic Physicians / Internal Medicine

CLEARWATER, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–11 of 11 matching records. This page contains 11 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1730284456?year=2024&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
SRIKANTH MALEMPATI, NPI 1730284456, CMS profile ID 78966. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–11 of 11 matching records. This page contains 11 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1730284456?year=2024&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). SRIKANTH MALEMPATI, NPI 1730284456, CMS profile ID 78966. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–11 of 11 matching records. This page contains 11 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1730284456?year=2024&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
SRIKANTH MALEMPATI, NPI 1730284456, CMS profile ID 78966, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–11 of 11 matching records. This page contains 11 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1730284456?year=2024&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

11 matching records · $219.12 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 11 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–11 of 11.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
SI-BONE, INC. $21.2512/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1120072151 CMS
GlaxoSmithKline, LLC. $20.7808/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1116199572 CMS
AstraZeneca Pharmaceuticals LP $15.7407/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105397976 CMS
Dexcom, Inc. $14.4205/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1153337545 CMS
Bayer Healthcare Pharmaceuticals Inc. $21.0804/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086187892 CMS
PFIZER INC. $6.0604/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131382297 CMS
PFIZER INC. $24.5703/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131401315 CMS
Bayer Healthcare Pharmaceuticals Inc. $34.1103/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086155682 CMS
GlaxoSmithKline, LLC. $16.9902/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1116717193 CMS
AstraZeneca Pharmaceuticals LP $21.2202/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105494663 CMS
Renalytix AI, Inc. $22.9001/09/2024 Food and Beverage No dispute reported Delay: No
Change: CHANGED
06/30/2026 1116759438 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $918.44 52
PY2020 $149.90 9
PY2021 $167.06 8
PY2022 $97.75 5
PY2023 $39.13 3
PY2024 $219.12 11
PY2025 $37.70 2

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $41,987.06 25
PY2024 Principal investigator $456,514.68 19
PY2023 Principal investigator $11,567.42 11
PY2022 Principal investigator $71,660.40 22
PY2021 Principal investigator $142,254.50 17
PY2020 Principal investigator $136,218.37 28
PY2019 Principal investigator $600,157.35 45

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

17 records in PY2021

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Bausch Health US, LLC $44,253.00 12/22/2021 Non-covered Recipient Entity
TAMPA BAY MEDICAL RESEARCH
A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, VEHICLE CONTROLLED, CLINICAL STUDY TO COMPARE THE SAFETY AND EFFICACY OF IDP-126 GEL TO EPIDUO? FORTE GEL (0.3% ADAPALENE/2.5% BPO), IN THE TREATMENT OF ACNE VULGARIS No dispute reported 06/30/2026 850502301
Principal investigator 1 Novartis Pharmaceuticals Corporation $1,275.00 12/22/2021 Non-covered Recipient Entity
TAMPA BAY MEDICAL RESEARCH
AN OPEN-LABEL EXTENSION TRIAL OF THE PHASE III LIPID-LOWERING TRIALS TO ASSESS THE EFFECT OF LONG TERM DOSING OF INCLISIRAN GIVEN AS SUBCUTANEOUS INJECTIONS IN SUBJECTS WITH HIGH CARDIOVASCULAR RISK AND ELEVATED LDL-C No dispute reported 06/30/2026 965470225
Principal investigator 1 ABBVIE INC. $468.00 12/09/2021 Non-covered Recipient Entity
TAMPA BAY MEDICAL RESEARCH
Testosterone Replacement therapy for Assessment of long-term Vascular Events and efficacy ResponSE in hypogonadal men (TRAVERSE) Study No dispute reported 06/30/2026 792486365
Principal investigator 1 ABBVIE INC. $2,959.50 11/09/2021 Non-covered Recipient Entity
TAMPA BAY MEDICAL RESEARCH
Testosterone Replacement therapy for Assessment of long-term Vascular Events and efficacy ResponSE in hypogonadal men (TRAVERSE) Study No dispute reported 06/30/2026 792481963
Principal investigator 1 Bausch Health US, LLC $30,590.50 11/05/2021 Non-covered Recipient Entity
TAMPA BAY MEDICAL RESEARCH
A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, VEHICLE CONTROLLED, CLINICAL STUDY TO COMPARE THE SAFETY AND EFFICACY OF IDP-126 GEL TO EPIDUO? FORTE GEL (0.3% ADAPALENE/2.5% BPO), IN THE TREATMENT OF ACNE VULGARIS No dispute reported 06/30/2026 850502281
Principal investigator 1 ABBVIE INC. $1,181.70 10/07/2021 Non-covered Recipient Entity
TAMPA BAY MEDICAL RESEARCH
Testosterone Replacement therapy for Assessment of long-term Vascular Events and efficacy ResponSE in hypogonadal men (TRAVERSE) Study No dispute reported 06/30/2026 792478227
Principal investigator 1 Bausch Health US, LLC $15,977.80 09/17/2021 Non-covered Recipient Entity
TAMPA BAY MEDICAL RESEARCH
A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, VEHICLE CONTROLLED, CLINICAL STUDY TO COMPARE THE SAFETY AND EFFICACY OF IDP-126 GEL TO EPIDUO? FORTE GEL (0.3% ADAPALENE/2.5% BPO), IN THE TREATMENT OF ACNE VULGARIS No dispute reported 06/30/2026 850502263
Principal investigator 1 ABBVIE INC. $1,181.70 09/08/2021 Non-covered Recipient Entity
TAMPA BAY MEDICAL RESEARCH
Testosterone Replacement therapy for Assessment of long-term Vascular Events and efficacy ResponSE in hypogonadal men (TRAVERSE) Study No dispute reported 06/30/2026 792474417
Principal investigator 1 Bausch Health US, LLC $4,174.80 08/20/2021 Non-covered Recipient Entity
TAMPA BAY MEDICAL RESEARCH
A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, VEHICLE CONTROLLED, CLINICAL STUDY TO COMPARE THE SAFETY AND EFFICACY OF IDP-126 GEL TO EPIDUO? FORTE GEL (0.3% ADAPALENE/2.5% BPO), IN THE TREATMENT OF ACNE VULGARIS No dispute reported 06/30/2026 850502233
Principal investigator 1 Bausch Health US, LLC $9,000.00 07/30/2021 Non-covered Recipient Entity
TAMPA BAY MEDICAL RESEARCH
A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, VEHICLE CONTROLLED, CLINICAL STUDY TO COMPARE THE SAFETY AND EFFICACY OF IDP-126 GEL TO EPIDUO? FORTE GEL (0.3% ADAPALENE/2.5% BPO), IN THE TREATMENT OF ACNE VULGARIS No dispute reported 06/30/2026 850502251
Principal investigator 1 ABBVIE INC. $9,679.00 07/29/2021 Non-covered Recipient Entity
TAMPA BAY MEDICAL RESEARCH
Testosterone Replacement therapy for Assessment of long-term Vascular Events and efficacy ResponSE in hypogonadal men (TRAVERSE) Study No dispute reported 06/30/2026 792469585
Principal investigator 1 ABBVIE INC. $104.00 07/08/2021 Non-covered Recipient Entity
TAMPA BAY MEDICAL RESEARCH
Testosterone Replacement therapy for Assessment of long-term Vascular Events and efficacy ResponSE in hypogonadal men (TRAVERSE) Study No dispute reported 06/30/2026 792467027
Principal investigator 1 ABBVIE INC. $3,089.70 05/27/2021 Non-covered Recipient Entity
TAMPA BAY MEDICAL RESEARCH
Testosterone Replacement therapy for Assessment of long-term Vascular Events and efficacy ResponSE in hypogonadal men (TRAVERSE) Study No dispute reported 06/30/2026 792460325
Principal investigator 1 ABBVIE INC. $6,223.30 04/29/2021 Non-covered Recipient Entity
TAMPA BAY MEDICAL RESEARCH
Testosterone Replacement therapy for Assessment of long-term Vascular Events and efficacy ResponSE in hypogonadal men (TRAVERSE) Study No dispute reported 06/30/2026 792448791
Principal investigator 1 ABBVIE INC. $5,819.50 03/30/2021 Non-covered Recipient Entity
TAMPA BAY MEDICAL RESEARCH
Testosterone Replacement therapy for Assessment of long-term Vascular Events and efficacy ResponSE in hypogonadal men (TRAVERSE) Study No dispute reported 06/30/2026 792436981
Principal investigator 1 ABBVIE INC. $3,855.50 03/02/2021 Non-covered Recipient Entity
TAMPA BAY MEDICAL RESEARCH
Testosterone Replacement therapy for Assessment of long-term Vascular Events and efficacy ResponSE in hypogonadal men (TRAVERSE) Study No dispute reported 06/30/2026 792427849
Principal investigator 1 ABBVIE INC. $2,421.50 01/28/2021 Non-covered Recipient Entity
TAMPA BAY MEDICAL RESEARCH
Testosterone Replacement therapy for Assessment of long-term Vascular Events and efficacy ResponSE in hypogonadal men (TRAVERSE) Study No dispute reported 06/30/2026 792414299